CClinicalTrials.gg
Status unknownNCT03982745Updated Jun 12, 2019

Double Lumen Tube Positioning With Bonfils Fiberoptic Stylet: Prospective Observational Study in 30 Adult Patients

An observational study in Difficult Intubation and Thoracic Surgery, sponsored by Università Politecnica delle Marche. Status unknown at 1 site in Italy. Per ClinicalTrials.gov, last updated 2019-06-12.

Sponsored by Università Politecnica delle Marche · Observational

The sponsor has not verified this record recently (last verified Jun 2019), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Sex
All
01

Study summary

The aim of this prospective observational study is to evaluate the efficacy of Bonfils fiberoptic stylet to perform tracheal intubation with double lumen tube after failure of standard laryngoscopy in 30 adults patients scheduled for elective thoracic surgery, who require tracheal intubation with double lumen tube for One Lung Ventilation under general anesthesia in a teaching hospital operating theatre at Ospedali Riuniti Ancona (Italy).

Read the detailed description

This is a prospective, observational study, approved by Marche's Regional Ethics Committee (CERM), Ancona, ITA on the 07 February 2019. The study is conformed to the Declaration of Helsinki and Good Clinical Practice guidelines, an informed written consent will be obtained at recruitment.

The aim of this study is to evaluate the efficacy of Bonfils fiberoptic stylet to perform tracheal intubation with double lumen tube (DLT) after failure of standard laryngoscopy in 30 adult patients (patients 18 years of age) scheduled for elective thoracic surgery, who require tracheal intubation with (DLT) for One Lung Ventilation (OLV) under general anesthesia. The study will be performed in a teaching hospital operating theatre at AOU Ospedali Riuniti Ancona (Italy).

Pre-operative evaluation will be done before surgery, demographic variables will be collected and the clinical screening tests to predict a difficult airway will be performed.

On the day of the intervention, patients will be subjected to standard monitoring of vital signs (NIBP, FC, SpO2 and ECG) and, after induction of general anesthesia and adequate pre-oxygenation (3-minutes with facial mask ventilation), a direct laryngoscopy with Macintosh blade will be performed to insert a DLT. The Cormack-Lehane grade view will be registered after optimization of the intubation attempt by improving the "sniffing position" and the external manipulation of the larynx (BURP maneuver). In case of declaration of intubation failure, it will be used Bonfils fiberscope for the DLT insertion.

A maximum duration of intubation attempt is not established, but a decrease in SpO2 below 90% will be considered as a criterion for abandoning the procedure and the patient will be re-oxygenated.

The maximum number of attempts allowed will be 2 for the Macintosh laryngoscope and 2 for the Bonfils fiberscope, after which, in case of failure with the both devices, the patient will be awakened.

In any case of difficulty in patient oxygenation and ventilation with facial mask, a second generation laryngeal mask will be used. The following parameters relating to the patients recruited in the study will be recorded: weight, height, BMI, Mallampati score, interincisor distance, chin-Thyroid distance, Cormack-Lehane view grade at direct laryngoscopy.

The primary end point of this study is to assess the success rate of DLT insertion with Bonfils fiberscope.

The duration of the procedure, the number of attempts and the occurrence of any complications will also be recorded

Data analysis will be performed using the Medcalc 7.3.0.1 statistical program (Medcalc software, Ostend, Belgium). Kolmogorov-Smirnov's test will be used to test the normality of distribution.

Data will be presented as mean ± dev. standard or median and 95% confidence interval.

The results will be averaged, and the data will be presented as mean SD for each variable with continuous data. Values of P less than 0.05 will be considered as statistically significant.

The differences between means will be studied by parametric tests (eg Student's t) if the data are normal distribution and non-parametric tests (eg Wilcoxon) if the distribution is not normal.

With regard to the efficacy of Bonfils fiberscope, literature have been reported a success rate higher than 80%. Therefore, assuming a success rate of around 90% (and accepting a standard deviation of 10%), we should study at least 30 patients for whom we expect to have a correct tracheal intubation on about 27 patients. A 5% SD would mean that intubation will be successful in at least 26 patients (85%), which we believe could be considered an excellent result.

02

Conditions studied

  • Difficult Intubation
  • Thoracic Surgery

Keywords

  • bonfils fiberoptic stylet
  • double lumen intubation
  • thoracic surgery
  • difficult intubation
  • difficult airway
03

In context

Lead sponsor

Università Politecnica delle Marche is the lead sponsor of 46 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adults (patients 18 years of age) scheduled for elective thoracic surgery, who require tracheal intubation with double lumen tube (DLT) for One Lung Ventilation (OLV) under general anesthesia in a teaching hospital operating theatre at Ospedali Riuniti Ancona.

Pre-operative evaluation will be done before surgery, demographic variables will be collected and the clinical screening tests to predict a difficult airway will be performed.

Inclusion criteria

  • adults (age≥18 years)
  • tracheal intubation with double lumen tube (DLT) for One Lung Ventilation (OLV) required for elective thoracic surgery under general anaesthesia

Exclusion criteria

Exclusion Criteria:

  • patients undergoing emergency thoracic surgery
  • patients with predictive criteria of difficult ventilation scheduled for "awake endoscopic intubation"
  • patients with anatomical features that contraindicate direct laryngoscopy
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (estimated)
Target follow-up
30 Days
Patient registry
Yes

Interventions

  • Devicebonfils

    bonfils intubation

06

What researchers measure

Primary outcomes

  1. the efficacy of Bonfils fiberoptic stylet to perform tracheal intubation with double lumen tube after failure of standard laryngoscopy

    the success rate of the procedure defined by the correct position of the double-lumen tube in the bronchial lumen verified by a flexible fiberscope

    Time frame: up to 2 minutes from device insertion

Secondary outcomes

  1. Time to intubation,

    Time in minutes measured from device insertion into the patient's mouth until the DLT will be positioned into the bronchial lumen.

    Time frame: up to 2 minutes from device insertion

  2. Any complications occurred

    number of patients that axperienced desaturation, hemodynamic alterations, oral cavity-pharynx and larynx traumatism

    Time frame: up to 12 hours measured from the insertion of the device

  3. Number of intubation attempts

    number of attempt to intubation. intubation will be considered complete when the DLT will be positioned correctly into the bronchial lumen.

    Time frame: up to 15 minutes. The maximum number of attempts allowed will be 2 for the Macintosh laryngoscope and 2 for the Bonfils fiberscope, after which, in case of failure with the both devices, the patient will be awakened.

07

Study locations

1 of 1 sites recruiting
  • AOU Ospedali Riuniti Ancona - Università Politecnica delle Marche
    Ancona, 60126, Italy
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 12, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03982745
Lead sponsor
Università Politecnica delle Marche
Responsible party
Abele Donati, MD (Director, Università Politecnica delle Marche) — Principal investigator
First posted
Jun 11, 2019
Start date
Mar 1, 2019
Primary completion
Mar 1, 2020 (estimated)
Completion
Mar 1, 2020 (estimated)
Last update
Jun 12, 2019

Study contacts

Abele Donati, PhD, MD
Contact
a.donati@univpm.it
0715963858
Stefano Falcetta, MD
Contact
falmed@libero.it
0715964603
Abele Donati, PhD, MD
study director · Università Politecnica delle Marche

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion